Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 30, 2013
Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosisDimitrios C Ziogas, Beatriz Gras-Miralles, Sarah Mustafa, et al.
Plos One|October 31, 2012
Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndromeKathryn T Hall, Anthony J Lembo, Irving Kirsch, et al.
European Journal of Gastroenterology & Hepatology|September 14, 2016
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problemDimitrios C Ziogas, Dionysios Papadatos-Pastos, Kiruthikah Thillai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2014
Asymptomatic bacteriuria in women with autoimmune rheumatic disease: prevalence, risk factors, and clinical significanceSarah P Georgiadou, Maria N Gamaletsou, Ioanna Mpanaka, et al.
Leukemia & Lymphoma|January 11, 2019
Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patientsMaria Gavriatopoulou, Despina Fotiou, Ursula Koloventzou, et al.
BMC Cancer|December 14, 2018
Management of uterine sarcomas and prognostic indicators: real world data from a single-institutionAnastasios Kyriazoglou, Michael Liontos, Dimitrios C Ziogas, et al.
American Journal of Hematology|December 29, 2018
Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonatesEvangelos Terpos, Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos, et al.
Annals of Hematology|March 6, 2019
Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcomeGeorgia Trakada, Efstathios Kastritis, Maria Gavriatopoulou, et al.
Leukemia|July 21, 2018
Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathiesTina Bagratuni, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Leukemia & Lymphoma|December 15, 2016
Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimensDimitrios C Ziogas, Efstathios Kastritis, Evangelos Terpos, et al.
Pageof 9